Question 1

Has Edward Chu received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $533,260 in general payments to Edward Chu across 48 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Edward Chu did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Edward Chu come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Bristol Myers Squibb	1	$437,741
Janssen Research & Development, LLC	30	$59,591
Astrazeneca UK Limited	2	$7,926
Medtronic	5	$7,252
Eisai Inc.	3	$6,850
AVEO Pharmaceuticals, Inc.	1	$5,000
Incyte Corporation	2	$4,515
GSK	1	$4,100
Abbott	1	$140
AstraZeneca	1	$124
Mirati Therapeutics, Inc.	1	$21

Edward Chu

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other hematology & oncology in Pittsburgh